SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report: February 17, 2005 (Date of earliest event reported) BIO-RAD LABORATORIES, INC. ________________________________________________________________ (exact name of registrant as specified in its charter) Commission File: 1-7928 Delaware 94-1381833 ________________________________________________________________ (State or other (I.R.S. Employer jurisdiction of Identification No.) incorporation or organization) 1000 Alfred Nobel Dr. Hercules, California 94547 ________________________________________________________________ (Address of Principal executive offices, including zip code) (510) 724-7000 ________________________________________________________________ (Registrant's telephone number, including area code) ITEM 2.02. RESULTS OF OPERATIONS AND FINANCIAL CONDITION. The information in Item 2.02 of this Report, including Exhibit 99.1 attached hereto, is being furnished pursuant to Item 2.02 of Form 8-K. Consequently, it is not deemed "filed" for the purposes of Section 18 of the Securities and Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. It may only be incorporated by reference in another filing under the Exchange Act or Securities Act of 1933, as amended, if such subsequent filing specifically references this Form 8-K. On February 17, 2005, Bio-Rad Laboratories, Inc. announced its results of operations and financial condition as of and for the fourth quarter ended December 31, 2004. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS. (c) Exhibits Exhibit Number Description 99.1 Press Release for fourth quarter financial results of Bio-Rad Laboratories, Inc., dated February 17,2005. This exhibit is being furnished pursuant to Item 2.02 of Form 8-K. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. BIO-RAD LABORATORIES,INC. Date: February 17, 2005 By: /s/ Christine A. Tsingos Christine A. Tsingos Chief Financial Officer EXHIBIT INDEX Exhibit Number Description 99.1 Press Release for fourth quarter financial results of Bio-Rad Laboratories, Inc., dated February 17, 2004. This exhibit is being furnished pursuant to Item 2.02 of Form 8-K.